Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
The Lancet. Neurology|June 28, 2017
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approachesAdam L Boxer, Jin-Tai Yu, Lawrence I Golbe, et al.
Experimental Neurology|May 18, 2004
Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutationPaul T Kotzbauer, Benoit I Giasson, Alexxai V Kravitz, et al.
Scientific Reports|January 19, 2020
Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured neuronsCarolina Alquezar, Jessica B Felix, Elizabeth McCandlish, et al.
Acta Neuropathologica|June 19, 2002
Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindredJohn E Duda, Benoit I Giasson, Meghann E Mabon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 27, 2022
Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy-Richardson SyndromeTao Xie, Anne-Marie Wills, Chuanhong Liao, et al.
Science (New York, N.Y.)|April 26, 2003
Initiation and synergistic fibrillization of tau and alpha-synucleinBenoit I Giasson, Mark S Forman, Makoto Higuchi, et al.
American Journal of Neurodegenerative Disease|December 10, 2013
Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutationsHiroshige Fujishiro, Akiko Yamashita Imamura, Wen-Lang Lin, et al.
Neurology|September 11, 2015
A geographical cluster of progressive supranuclear palsy in northern FranceDominique Caparros-Lefebvre, Lawrence I Golbe, Vincent Deramecourt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2024
Combined Assessment of Function and Survival to Demonstrate the Effect of Treatment on Progressive Supranuclear PalsyMassimiliano Germani, Irene Rebollo Mesa, Tim J Buchanan, et al.
Acta Neuropathologica Communications|September 4, 2019
Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progressionZachary A Sorrentino, Marshall S Goodwin, Cara J Riffe, et al.
Pageof 5